Researchers have harnessed the power of artificial intelligence to design a blueprint for building a vaccine that aims to ...

Early data suggest personalized neoantigen vaccines activate the immune system and sustain tumor control in some patients with kidney cancer.

Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 pandemic. Prophylactic cancer vaccines have prevented several malignancies by ...

Toward a Computable Phenotype for Determining Eligibility of Lung Cancer Screening Using Electronic Health Records Accurate human leukocyte antigen (HLA) typing is an essential step for designing ...

Birmingham's Queen Elizabeth Hospital is taking part in a trial of a groundbreaking cancer vaccine.

A new breast cancer vaccine will be moving forward to the next stages of development and may soon be able to stop cancerous tumors from forming. Here’s what you need to know.

Researchers at Case Western Reserve University and Cleveland Clinic are developing vaccines targeting pancreatic cancer that could eliminate the disease, leaving a patient cancer-free. So far, the ...

Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer Society.

Researchers say the vaccine, developed by Anixa Biosciences and funded by the Department of Defense, could eliminate breast cancer - which one out of eight women will get in her life - by 2030.

This study presents a nanovaccine platform that uses tumor-derived membranes and a synthetic adjuvant to improve personalized cancer vaccine development. The approach allows for broader neoantigen ...